Tisotumab Vedotin in Patients With Previously Treated Recurrent or Metastatic Cervical Cancer: Updated Safety and Efficacy Results From the Phase II innovaTV 201 Study
2019
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI